ADMA BIOLOGICS, INC. Other Non-Current Liabilities
ADMA BIOLOGICS, INC. (ADMA) had Other Non-Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-02-25
- 2025-12-31: Other Liabilities, Noncurrent $0.00.
- 2025-09-30: Other Liabilities, Noncurrent $90.00K.
- 2025-06-30: Other Liabilities, Noncurrent $2.00K.
- 2025-03-31: Other Liabilities, Noncurrent $2.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |
| 2025-09-30 | $90.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $360.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $375.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $390.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $405.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $419.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $434.65K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $449.51K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $338.73K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $350.00K 10-K · filed 2024-02-28 | $350.45K 10-K · filed 2023-03-23 |
| 2022-09-30 | $362.18K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $373.90K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $385.63K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $397.35K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $232.66K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $36.15K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $41.97K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $54.89K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $67.81K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $80.73K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $93.65K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $106.57K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $119.50K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $132.42K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $145.34K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $260.73K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $277.69K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $347.90K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $309.35K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $106.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $118.32K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $93.94K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $1.79M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $117.81K 10-K · filed 2018-03-29 | $1.79M 10-K · filed 2017-02-24 |
| 2016-09-30 | $1.79M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.79M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $1.43M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $1.43M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $1.43M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.43M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $132.50K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $132.50K 10-K · filed 2016-03-23 | |
| 2014-09-30 | $132.50K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $132.50K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $132.50K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $132.50K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $132.50K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $132.50K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $132.50K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $106.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |